SPEX CertiPrep Revenue and Competitors
Estimated Revenue & Valuation
- SPEX CertiPrep's estimated annual revenue is currently $7.5M per year.
- SPEX CertiPrep's estimated revenue per employee is $34,404
Employee Data
- SPEX CertiPrep has 218 Employees.
SPEX CertiPrep's People
Name | Title | Email/Phone |
---|
SPEX CertiPrep Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 20 | -5% | N/A | N/A |
#2 | $35M | 156 | -13% | N/A | N/A |
#3 | N/A | 5685 | 0% | N/A | N/A |
#4 | $35M | 351 | N/A | N/A | N/A |
#5 | $750M | 1802 | 25% | N/A | N/A |
#6 | $35M | 363 | 1% | N/A | N/A |
#7 | $300M | 255 | 10% | N/A | N/A |
#8 | $7.5M | 74 | 4% | N/A | N/A |
#9 | $75M | 1161 | 17% | N/A | N/A |
#10 | N/A | 8 | 0% | N/A | N/A |
What Is SPEX CertiPrep?
SPEX CertiPrep has been servicing the scientific community since 1954. We are a leading manufacturer of Certified Reference Materials (CRMs) and Calibration Standards for Analytical Spectroscopy and Chromatography. We offer a full range of Inorganic and Organic CRMs. We are certified by DQS to ISO 9001:2015 and are proud to be accredited by A2LA to ISO/IEC 17025:2005 and ISO 17034:2016. The scope of our accreditation is the most comprehensive in the industry and encompasses all of our manufactured products.
keywords:N/AN/A
Total Funding
218
Number of Employees
$7.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
SPEX CertiPrep News
Merck KGaA, LGC Limited, SPEX CertiPrep, Restek Corporation, Agilent Technologies, Inc, AccuStandard, Inc., PerkinElmer Inc, Thermo Fisher...
Major companies included in the report are : Merck; Agilent Technologies; Waters; Restek; Spex Certiprep; Accustandard; LGC Standards; Perkinelmer; Thermo...
... LGC Limited, SPEX CertiPrep, Restek Corporation, Agilent Technologies, Inc, AccuStandard, PerkinElmer Inc, Thermo Fisher Scientific,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $60.5M | 219 | 13% | N/A |
#2 | $416.2M | 1386 | 12% | $4.1M |